Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
REDSTONE ARSENAL, Ala. (July 23, 2025) – The U.S. Army Redstone Test Center’s Propulsion Test Division has long served as the Army’s premier static test facility, boasting a rich history of evaluating ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
Findings showed in the ITT population, zanzalintinib plus atezolizumab statistically significantly reduced the risk of death compared with regorafenib. Topline data were announced from a phase 3 trial ...
Gaming Monitors With DRAM and SSDs now all stupidly expensive, upgrade your gaming setup with this $260 ultra-curved, ultrawide monitor instead Gaming Laptops Best gaming laptop 2026: I've tested the ...
ABSTRACT: Security vulnerabilities are a widespread and costly aspect of software engineering. Although tools exist to detect these vulnerabilities, non-machine learning techniques are often rigid and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results